SCHEMBL23301626

SCHEMBL23301626

COC(=O)c1cccc(CN2CCN(C(=O)OC(C)(C)C)CC2)c1C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VEGFA P15692 1/20 0.45
▸ EGLN1 Q9GZT9 1/20 0.45
▸ CHRM2 P08172 1/20 0.45
▸ CHRM4 P08173 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ CHRM3 P20309 1/20 0.45
▸ MMP1 P03956 1/20 0.45
▸ MMP9 P14780 1/20 0.45
▸ MMP13 P45452 1/20 0.45
▸ ADAM17 P78536 1/20 0.45
▸ NR1H2 P55055 1/20 0.44
▸ ALDH1A1 P00352 6/20 0.43
▸ POLB P06746 2/20 0.43
▸ KDM4E B2RXH2 5/20 0.43
▸ HTT P42858 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ ACKR3 P25106 1/20 0.42
▸ ABCB1 P08183 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28701016 0.90 CHRM2 (0.50) VEGFAEGLN1CHRM2CHRM4CHRM1
Hydrochloric Acid SCHEMBL23301148 0.83 VEGFA (0.46) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL15192026 0.82 CHRM2 (0.46) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL30576825 0.80 CHRM2 (0.52) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL15264751 0.80 VEGFA (0.45) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL15263897 0.79 VEGFA (0.54) VEGFAEGLN1MMP1MMP9MMP13
SCHEMBL3201033 0.79 VEGFA (0.47) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL15265349 0.78 ALDH1A1 (0.55) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL14847422 0.78 MGLL (0.46) VEGFAEGLN1CHRM2CHRM4CHRM1
SCHEMBL19992955 0.77 MGLL (0.53) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051674-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2022-09-07 — — EP disclosed
CN-114728936-A Bifunctional compounds for the treatment of cancer 豪夫迈·罗氏有限公司 2022-07-08 — — CN disclosed
WO-2021083949-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2021-05-06 — — WO disclosed
Send feedback